I think IRAP is due for a review right now, and I'm calling for that to be done in consultation with companies, in order for us to take advantage of them.
October 6th, 2025 / 12:50 p.m.
Chair, Canadian Antimicrobial Innovation Coalition and Chief Scientific Officer, Fedora Pharmaceuticals Inc.)
I think IRAP is due for a review right now, and I'm calling for that to be done in consultation with companies, in order for us to take advantage of them.
See context to find out what was said next.